Indeed, inhibiting IL-8 with a function-blocking antibody not only reduced GBM tumor cell invasion by 55%, but also significantly diminished the number of nestin positive cells in GBM-endothelial cell co-cultures (Fig. 5a,b). The gene discussed is NES; the disease is glioblastoma.